{"name": "Nautilus Neurosciences",
 "permalink": "nautilus-neurosciences",
 "crunchbase_url": "http://www.crunchbase.com/company/nautilus-neurosciences",
 "homepage_url": "http://www.nautilusneurosciences.com/",
 "blog_url": "http://nautilusneurosciences.com/news/",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2009,
 "founded_month": null,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "info@nautilusneurosciences.com",
 "phone_number": "908-437-1320",
 "description": "",
 "created_at": "Wed Dec 09 19:21:56 UTC 2009",
 "updated_at": "Sat Apr 06 04:42:16 UTC 2013",
 "overview": "\u003Cp\u003ENautilus Neurosciences is a neurology-focused specialty pharmaceutical company committed to providing the healthcare community with relevant products and services that directly benefit those affected by neurological disorders.\u003C/p\u003E\n\n\u003Cp\u003EIn the first half of 2010, Nautilus intends to launch a novel product, CAMBIA\u00ef\u00bf\u00bd (diclofenac potassium for oral solution).\u003C/p\u003E\n\n\u003Cp\u003ENautilus is backed by Tailwind Capital, a leading private equity firm that invests in health care, business services and media/communications companies. \u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       42],
      "assets/images/resized/0007/9946/79946v1-max-150x150.jpg"],
     [[250,
       71],
      "assets/images/resized/0007/9946/79946v1-max-250x250.jpg"],
     [[450,
       128],
      "assets/images/resized/0007/9946/79946v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO",
    "person":
     {"first_name": "William",
      "last_name": "Maichle",
      "permalink": "william-maichle",
      "image": null}},
   {"is_past": false,
    "title": "Founder and President",
    "person":
     {"first_name": "Eric",
      "last_name": "Liebler",
      "permalink": "eric-liebler",
      "image": null}},
   {"is_past": false,
    "title": "CFO",
    "person":
     {"first_name": "Neil",
      "last_name": "Milano",
      "permalink": "neil-milano",
      "image": null}},
   {"is_past": false,
    "title": "Director",
    "person":
     {"first_name": "Douglas",
      "last_name": "Karp",
      "permalink": "douglas-karp",
      "image":
       {"available_sizes":
         [[[150,
            142],
           "assets/images/resized/0007/1667/71667v1-max-150x150.jpg"],
          [[250,
            237],
           "assets/images/resized/0007/1667/71667v1-max-250x250.jpg"],
          [[450,
            427],
           "assets/images/resized/0007/1667/71667v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Director",
    "person":
     {"first_name": "Geoffrey",
      "last_name": "Raker",
      "permalink": "geoffrey-raker",
      "image":
       {"available_sizes":
         [[[150,
            141],
           "assets/images/resized/0007/1669/71669v1-max-150x150.jpg"],
          [[250,
            236],
           "assets/images/resized/0007/1669/71669v1-max-250x250.jpg"],
          [[450,
            425],
           "assets/images/resized/0007/1669/71669v1-max-450x450.jpg"]],
        "attribution": ""}}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$25M",
 "funding_rounds":
  [{"round_code": "a",
    "source_url": "http://onbiovc.com/nautilus-neurosciences-inc-series-a-145m/",
    "source_description": "Nautilus Neurosciences, Inc.: Series A $14.5M",
    "raised_amount": 14500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 3,
    "funded_day": 11,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Tailwind Capital",
         "permalink": "tailwind-capital",
         "image":
          {"available_sizes":
            [[[150,
               18],
              "assets/images/resized/0006/9079/69079v1-max-150x150.jpg"],
             [[250,
               31],
              "assets/images/resized/0006/9079/69079v1-max-250x250.jpg"],
             [[314,
               39],
              "assets/images/resized/0006/9079/69079v1-max-450x450.jpg"]],
           "attribution": null}},
       "person": null}]},
   {"round_code": "a",
    "source_url": "http://www.fiercebiotech.com/story/nautilus-gets-funding-support-migraine-drug-launch/2010-04-13",
    "source_description": "Nautilus gets funding to support migrane drug launch",
    "raised_amount": 10500000.0,
    "raised_currency_code": "USD",
    "funded_year": 2010,
    "funded_month": 4,
    "funded_day": 22,
    "investments":
     [{"company": null,
       "financial_org":
        {"name": "Galen Partners",
         "permalink": "galen-partners",
         "image":
          {"available_sizes":
            [[[142,
               97],
              "assets/images/resized/0003/3679/33679v1-max-150x150.png"],
             [[142,
               97],
              "assets/images/resized/0003/3679/33679v1-max-250x250.png"],
             [[142,
               97],
              "assets/images/resized/0003/3679/33679v1-max-450x450.png"]],
           "attribution": null}},
       "person": null}]}],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "1200 Route 22 East",
    "address2": "Suite 2000",
    "zip_code": "08807",
    "city": "Bridgewater",
    "state_code": "NJ",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [],
 "external_links":
  []}